Anti-Obesity and Antidiabetic Effects of Fig (Ficus carica L.) Fermented Extract Using Lactobacillus plantarum BT-LP-01

Author:

Choi Hwal1ORCID,Choi Jihye1ORCID,Jang Yuseong1,Lee Young-Min2,Kang Myoung-Hak2,Kwon Hyuck-Se3,Kim Sokho14,Kwon Jungkee1

Affiliation:

1. Department of Laboratory Animal Medicine, College of Veterinary Medicine, Jeonbuk National University, 79 Gobong-ro, Iksan-si 54596, Republic of Korea

2. Alldayorganic Co., Ltd., 30-39 Gojeong 1-ro 82 beon-gil, Gimpo-si 10009, Republic of Korea

3. R&D Team, Food & Supplement Health Claims, Vitech Co., Ltd., #602 Giyeon B/D 141 Anjeon-ro, Iseo-myeon, Wanju-gun 55365, Republic of Korea

4. School of Liberal Studies, Regulatory Science Major, Kunsan National University, 558 Daehak-ro, Gunsan-si 54150, Republic of Korea

Abstract

This study aimed to assess the effect of fermented fig (Ficus carica L., FF) on obesity and diabetes in a mouse model. FF was cultured with the lactic acid bacterium Lactobacillus plantarum BT-LP-01 and isolated from fig peels. The antioxidant results demonstrated that FF exhibited DPPH and ABTS radical scavenging activities. In addition, FF showed high levels of total polyphenol and total flavonoids. Body and organ weight and dietary intake were significantly decreased in the FF groups compared to the HFD group. The FF group showed improved recovery in lipid metabolism and liver function compared to the HFD group. In addition, the FF group showed a significant decrease in serum C-P and insulin concentrations compared to the HFD group. FF-administered mice showed a dose-dependent recovery of fasting blood glucose and IPGTT and AUC levels compared to the HFD group. Furthermore, FF groups showed a decreased expression in FAS, C/EBPα, and FABP4, as well as significantly increased expression in ACC in the liver. This study demonstrates that FF is effective in reducing and inhibiting adipogenesis as well as lowering body weight, the blood glucose level, and lipid-related factors. These research findings demonstrate that FF is effective in treating obesity and diabetes.

Funder

Starting Growth Technological R&D Program

Publisher

MDPI AG

Reference78 articles.

1. NCD Risk Factor Collaboration (NCD-RisC) (2017). Worldwide trends in body-mass index, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet, 390, 2627–2642.

2. Inhibition of triglyceride synthesis as a treatment strategy for obesity: Lessons from DGAT1-deficient mice;Chen;Arterioscler. Thromb. Vasc. Biol.,2005

3. Transcriptional factors that promote formation of white adipose tissue;White;Mol. Cell Endocrinol.,2009

4. Adipocyte differentiation from the inside out;Rosen;Nat. Rev. Mol. Cell Biol.,2006

5. Adipose tissue and atherothrombosis;Alessi;Pathophysiol. Haemost. Thromb.,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3